Fig. 3From: Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastasesGenomic alterations by the timing of metastasis. A Gene-level mutation prevalence in synchronous and metachronous liver metastases. B Pathway-level mutation prevalence in synchronous and metachronous liver metastases. Significant elements are labeled as red circlesBack to article page